Brief: 10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
03/03/2025 22:23
March 3 (Reuters) - 10X Genomics Inc TXG.O: 10X GENOMICS SECURES INJUNCTION AGAINST PARSE BIOSCIENCES' PLANNED ATAC PRODUCTS 10X GENOMICS: CO'S LITIGATION AGAINST PARSE'S GENE EXPRESSION PRODUCTS REMAINS ONGOING Source text: ID:nPn5K03n4a Further company coverage: TXG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences